- 124 pages
- English
- ePUB (mobile friendly)
- Available on iOS & Android
Successes and Limitations of Targeted Cancer Therapy
About This Book
The treatment of patients with advanced malignancies has undergone remarkable change in the last few years. While in the past decisions about systemic therapy were largely based on the performance status of a patient, oncologists today also take into account the pathological and molecular characteristics of the patient's tumor. Targeting specific molecular pathways important for tumorigenesis has become the preferred way of treatment for many types of malignancies. With these advances come new challenges including the optimization of therapy, recognizing and dealing with side effects and, importantly, the development of resistance. This book provides an up-to-date overview of the advances and limitations of targeted therapy for several tumor entities including breast cancer, colon cancer, gastrointestinal stromal tumors, lung cancer, melanoma, ovarian cancer and renal cell carcinoma. Written by over a dozen internationally renowned scientists, the book is suitable for advanced students, postdoctoral researchers, scientists and clinicians who wish to update their knowledge of the latest approaches to targeted cancer therapies.
Frequently asked questions
Table of contents
- Cover Page
- Front Matter
- Targeting Oncogenic Drivers
- Successes and Limitations of Targeted Cancer Therapy in Breast Cancer
- Successes and Limitations of Targeted Cancer Therapy in Colon Cancer
- Successes and Limitations of Targeted Cancer Therapy in Gastrointestinal Stromal Tumors
- Successes and Limitations of Targeted Cancer Therapy in Lung Cancer
- Successes and Limitations of Targeted Cancer Therapy in Melanoma
- Successes and Limitations of Targeted Cancer Therapy in Ovarian Cancer
- Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma
- Author Index
- Subject Index